The ASCO Nominating Committee has selected 13 distinguished members as candidates for open leadership positions within the Society. ASCO encourages all eligible members to cast their ballots to choose ...

Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...

Sana Biotechnology, CAMP4 Therapeutics and Crinetics Pharmaceuticals have all used the third quarter to refocus their ...

Interim Phase 1 results for APG333 exceeded trial objectives, demonstrated a half-life of approximately 55 days, and suppressed key biomarkers ...

The mandatory Phase 1 clinical trial in healthy volunteers in China precedes the inclusion of Chinese clinical sites by late 2026 into the single Global Phase 3 registration trial of BV100 in ...

Korro amended its research collaboration and license agreement with Novo Nordisk A/S (Novo Nordisk). This amendment establishes a 12-month pause to reassess the rationale for the current target under ...

R&D Expenses: Research and development expenses for the quarter ended September 30, 2025, were $9.4 million, compared to $9.7 million for the quarter ended September 30, 2024. The expenses were ...

Hundreds of health care artificial intelligence (AI) tools have been cleared by the U.S. Food and Drug Administration (FDA), yet only a fraction are rigorously evaluated for clinical impact, fairness ...

Absci accelerates ABS-201 in alopecia & endometriosis, targets data by 2027, and refocuses pipeline for value.

Thomas George, M.D., FACP, FASCO, an accomplished gastrointestinal medical oncologist and nationally known expert in clinical ...

One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways: IAVI's Lassa vaccine candidate rVSVΔG-LASV-GPC has an acceptable safety profile and ...

The Pennsylvania Department of Health will cut 25% of funding to the Part B of the Ryan White HIV/AIDS Program amid rising need and tighter eligibility rules.